PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
118.91%
Cash & equivalents growing 118.91% while AVXL's declined -37.55%. Peter Lynch would see this as a sign of superior liquidity management.
No Data
No Data available this quarter, please select a different quarter.
118.91%
Below half of AVXL's -37.55%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
104.59%
Below half of AVXL's -40.38%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
15.06%
Below half AVXL's -44.62%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-15.06%
Higher Other Non-Current Assets Growth compared to AVXL's zero value, indicating worse performance.
15.06%
Below half of AVXL's -44.62%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
104.51%
Below half of AVXL's -40.58%. Michael Burry sees a potential red flag for stagnation or capital shortage.
55.57%
Higher Accounts Payable Growth compared to AVXL's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
719.98%
Exceeding 1.5x AVXL's 16.53%. Michael Burry suspects ballooning short-term obligations vs. competitor.
14812.60%
Above 1.5x AVXL's 30.11%. Michael Burry sees a red flag for liquidity risk vs. competitor.
-100.00%
Higher Long-Term Debt Growth compared to AVXL's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Higher Total Non-Current Liabilities Growth compared to AVXL's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
4364.90%
Above 1.5x AVXL's 30.11%. Michael Burry sees a potential leverage warning sign.
91.77%
Above 1.5x AVXL's 0.25%. Michael Burry suspects heavy new equity expansion or dilution.
-19849.13%
≥ 1.5x AVXL's -1.84%. David Dodd sees higher yoy retained profits than competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1201.65%
Below half AVXL's -30.82%. Michael Burry sees potential underperformance in building shareholder capital.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
92.16%
Less than half of AVXL's 510.20%. David Dodd sees less overall debt expansion vs. competitor.
-119.69%
Less than half of AVXL's 833.74%. David Dodd sees better deleveraging or stronger cash buildup than competitor.